Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance: Importance of Whole-Body versus Spinal MR Imaging
Authors:
- Tobias BäuerleTBTobias Bäuerle
- Jens HillengassJHJens Hillengass
- Kerstin FechtnerKFKerstin Fechtner
- Christian M. ZechmannCZChristian M. Zechmann
- Lars GrenacherLGLars Grenacher
- Thomas M. MoehlerTMThomas M. Moehler
- Heiss ChristianeHCHeiss Christiane
- Wagner-Gund BarbaraWBWagner-Gund Barbara
- Kai NebenKNKai Neben
- Hans-Ulrich KauczorHKHans-Ulrich Kauczor
- Hartmut GoldschmidtHGHartmut Goldschmidt
- Stefan DelormeStefan Delorme
- 1 August 2009
- journal article
- research article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 252 (2) , 477-485
Abstract
As extra-axial focal lesions can not be excluded in monoclonal gammopathy of undetermined significance or multiple myeloma by using spinal MR imaging and serologic parameters, we recommend the use of whole-body MR imaging for initial work-up in these patients. PurposeTo examine if standard magnetic resonance (MR) imaging of the axial skeleton is sufficient for evaluation of patients with multiple myeloma (MM) or monoclonal gammopathy of undetermined significance (MGUS) or if whole-body MR is necessary. Materials and MethodsA total of 100 untreated patients with MGUS (n = 27) or any stages of MM (n = 73) were examined with whole-body MR imaging and MR imaging of the axial skeleton. The study was approved by the institutional ethics committee, and written informed consent was given. Spinal pattern (“no diffuse involvement” or “diffuse involvement” as assessed from the signal intensity of the spinal bone marrow), serum parameters, and stage of disease were correlated with the probability of detecting extra-axial lesions with and without destruction of cortical bone by using a multiple logistic regression model. ResultsOf 100 patients, 39 had lesions in the axial skeleton and 37 had lesions in the extra-axial skeleton. Of the latter group, nine patients had no axia...Keywords
This publication has 22 references indexed in Scilit:
- Whole-Body MRI Versus Whole-Body MDCT for Staging of Multiple MyelomaAmerican Journal of Roentgenology, 2008
- Magnetic Resonance Imaging in Multiple Myeloma: Diagnostic and Clinical ImplicationsJournal of Clinical Oncology, 2007
- The role of anatomic and functional staging in myeloma: Description of Durie/Salmon plus staging systemEuropean Journal of Cancer, 2006
- Role of MRI for the diagnosis and prognosis of multiple myelomaEuropean Journal of Radiology, 2005
- Multiple myelomaCancer Imaging, 2004
- Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma FoundationThe Hematology Journal, 2003
- Magnetic resonance imaging as a supplement for the clinical staging system of Durie and Salmon?Cancer, 2002
- Multidetector CT of the Spine in Multiple Myeloma: Comparison with MR Imaging and RadiographyAmerican Journal of Roentgenology, 2002
- A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined SignificanceNew England Journal of Medicine, 2002
- Contrast enhancement and quantitative signal analysis in MR imaging of multiple myeloma: assessment of focal and diffuse growth patterns in marrow correlated with biopsies and survival rates.American Journal of Roentgenology, 1996